血栓管理设备市场：按细分市场划分的规模、份额、法规、报销、程序、到 2033 年的预测

静脉血栓栓塞（VTE）是指深部静脉栓塞（DVT）和肺栓塞（PE）的术语。 当深层静脉形成血块，限制血流时，就会发生 DVT。 另一方面，如果血块或血块的一部分进入血流并到达肺部，则可能导致肺栓塞。 经皮机械血栓切除术透过抽吸、浸渍和/或破碎去除血块或栓塞。 机械血栓切除术对于容易发生血栓溶解药物副作用影响的患者非常有用。 直接导管溶栓是治疗 DVT 和 PE 的常用血管内方法。 它也可用于没有溶栓治疗禁忌的患者。 此细分市场涵盖血栓切除系统（导管）、手动抽吸血栓切除装置、旋转血栓切除装置、栓子清除球囊装置、标准导管直接溶栓导管（CDT）、超音波辅助导管直接溶栓导管。

本报告深入了解全球血栓管理设备市场，提供竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响、区域和国家趋势等。

目录

目前市面上血栓管理设备及竞争状况

• 对主要产业趋势的见解
• 2015 年至 2033 年血栓管理设备各细分市场的市场总收入及市场前景
• 按细分市场划分的手术总数、单位数量、平均售价和市场价值的详细数据

全球、区域与国家见解

• 血栓管理设备市场的SWOT分析
• 血栓管理设备市场的竞争动态洞察与趋势
• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技的监管状况

Clot Management Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Clot Management Devices market for the year 2020 and beyond. Venous Thromboembolism (VTE) is a term that refers to Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). DVT occurs when a blood clot forms in the deep veins, which can result in restricted blood flow whereas when the clot or part of it migrates through the bloodstream and reaches the lungs, it causes a Pulmonary Embolism. Percutaneous Mechanical Thrombectomy removes the thrombus or emboli by aspiration, maceration and/or fragmentation. Mechanical Thrombectomy is useful in patients who are susceptible to the side effects of thrombolytic drugs. Catheter-Directed Thrombolysis is a commonly-used endovascular approach in the treatment of DVT and PE. It can be used in patients who are not contraindicated for Thrombolysis. Thrombectomy Systems (Catheters), Manual Aspiration Thrombectomy Devices, Rotational Thrombectomy Devices, Embolectomy Balloon Devices, Standard Catheter Directed Thrombolysis catheter (CDT) and Ultrasound-assisted Catheter Directed Thrombolysis catheter are segments that are covered in this market.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Clot Management Devices market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Clot Management Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Clot Management Devices market.
• Competitive dynamics insights and trends provided Clot Management Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Inari Medical Inc, Boston Scientific Corp, Penumbra Inc, Teleflex Inc, Edwards Lifesciences Corp, Medtronic Plc, Argon Medical Devices Inc, LeMaitre Vascular Inc, AngioDynamics Inc, Terumo Corp, Merit Medical Systems Inc, Cook Medical Inc, Koninklijke Philips NV, Control Medical Technology LLC, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Clot Management Devices market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Clot Management Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Clot Management Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Clot Management Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Clot Management Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable